Our 2025 Partners
Expertise Partners:
Almac Clinical Services
Almac Clinical Services dedicated Unlicensed Medicine Services group currently manage over 200+ active Managed Access programs, delivering critical medication to patients across 80 countries worldwide. From forecasting and production through to storage and distribution, Almac provides the global reach, expert people, validated processes, and cutting edge technology to empower sponsors to maintain ethical, compliant, and cost- effective access to unlicensed treatments.
Early Access Care
Early Access Care is a full-scale specialist service provider of Compassionate Use and Named Patient Programs, ranging from programme planning, protocol development, end-to-end operational management, Real World Data services, and a variety of customized service offerings. We work with biotech and pharmaceutical companies to set up and manage programs in the pre and post-approval space, including post-trial access, managing all regulatory and logistical aspects of early access. Speak with one of our representatives at the EAC booth to find out more about how our service and staff may support your plans.
Inceptua Early Access
Inceptua Group (Inceptua) is a provider of customized access solutions that enable pharmaceutical companies to overcome challenges and eliminate obstacles to reach patients with unmet medical needs and provide access to life-changing or life-extending therapies. The group was founded in 1997, initially focused on sourcing comparator products and delivering services for clinical trials. Later Inceptua was expanded in 2017 with the establishment of Inceptua Early Access, running early access programs worldwide. Inceptua’s Early Access team combine regulatory and operational expertise with an ability to partner effectively with clients to confidently provide the guidance, recommendations and capabilities necessary to successfully plan for and execute global access programs. Collectively, our experience covers 300+ early access programs, involving both free-of-charge and charged for products treating a variety of conditions, including many rare and orphan indications. Our team leverage a wealth of expertise in managing the distribution of medicines to more than 120 countries around the world, including North America, the EU, LATAM, MENA, APAC regions and low/middle income countries across the globe.
WEP
At WEP, we are With Every Patient, as we believe every patient should have access to treatment! We operate as a Pharma Services Provider (PSP) that is committed to providing Drug Development and Treatment Access Solutions for patients worldwide. We specialize in Expanded Access Programs (EAPs) and help Sponsors deliver value-driven EAPs that are designed and fit
around their specific needs and development pipeline. Our programs are delivered through High Quality, High Service, and High Value, returning a positive ROI to all Sponsors we have partnered with.
Hosting Partners:
BAP Pharma
BAP Pharma is an award-winning, responsive and cost-effective medicines access solutions partner, specialising in providing tailored access solutions to health care professionals and patients. Our experts in Early and Managed Access Programs (EAP/MAP) can assist and support your efforts to bring critical treatments to patients in need, ensuring they get the medicines they need, when they need them, anywhere in the world.
Bionical Emas
Bionical Emas is a global Early Access Programs (EAP) specialist bringing life-changing medicines to patients around the world. Their comprehensive suite of services and capabilities benefit many of the world’s leading pharma and biotech companies.
Bionical Emas provides in-house, highly specialized and EAP centric clinical services, including dedicated Real-World Evidence, Pharmacovigilance and Medical teams to support all program requirements. Their vast experience in oncology and rare disease, and dedicated EAP teams and processes, are essential to providing innovative EAP solutions to pharma and biotech companies globally.
With a truly patient focused approach, Bionical Emas offers a best-in-class EAP service offering ensuring patient, healthcare professional and client needs are met through passionate and tailored program delivery.
myTomorrows
myTomorrows is a global health tech company dedicated to helping patients and physicians discover and access treatment options. We’ve partnered with 50+ BioPharma companies to support global expanded access programs, gather invaluable real-world data, and streamline patient recruitment for clinical trials. We are experts in the field of expanded access, having gained
experience over a decade, and we manage all aspects of expanded access - from regulatory strategy program setup to full operational execution. We distinguish ourselves by taking a proactive stakeholder-focused approach.
Event Partners:
MedaSystems
MedaSystems' software is trusted by pharmaceutical companies across the United States and Europe to enhance patient outcomes and streamline the management of drugs under various pre-approval access pathways. Numerous major academic institutions actively use it, and our research and development efforts are grounded in thousands of hours spent collaborating with experts in global pre-approval access.
Life Science Companies use MedaSystems to:
- Easily collaborate with healthcare providers
- Make approval decisions faster
- Reduce frustrating repetitive manual steps
- Capture real-world data
- Comply with regulations
Cisiv
Cisiv is an innovative technology company providing software that supports the pharmaceutical industry in its work with licensed medicines and medicines distributed through MAPs. Our cutting-edge platform, Baseline Plus, is an integrated solution including Managed Access, Safety Reporting, Real World Data capture, eConsent, ePro and surveys. It has been used for over 10 years by leading global companies in extensive, international MAPs, prospective observational studies and combined activities where RWD is collected with a MAP.
Baseline Plus is compliant with all applicable global requirements including 21 CFR Part 11, GCP, GDPR, and HIPAA and. Our MAP platform enables streamlined request management, controlled approval processes and a unified experience for HCPs and pharmacists through highly configurable role-based workflows. Cisiv’s mission is to provide technology to support pharmaceutical companies with the process and data capture that bring medicines closer to patients.
Clinigen
Clinigen is a global, specialist pharmaceutical services company focused on providing ethical access to medicines for over 35 years. With experience of over 400+ Managed Access programs worldwide and lifesaving medicines delivered to more than 100,000 patients, we are the market leaders in delivering Managed Access programs and driving thought leadership with proven operational expertise within Early Access. We are dedicated to giving healthcare professionals and their patients greater access to medicines globally.
Uniphar
Uniphar is a trusted global partner to pharma, medtech and biotech companies, working to improve patient access to medicines around the world. Uniphar’s team of experts harness the capabilities, infrastructure and expertise of a diversified pharmaceutical service provider with more than 57 years’ building success stories with 200+ multinational clients. Our understanding of the shifting market dynamics allows us to deliver tailored specialist solutions for our clients’ changing needs throughout the product lifecycle, from expanded access programs to strategic regulatory support to commercial execution.
Uniphar Pharma comprises Uniphar | Access, Uniphar | Medical, and Uniphar | Commercial – together our combined capabilities allow us to be your trusted partner to unlock access to innovative therapies and optimise value for brands globally. Partnering from clinical development to commercialisation, Uniphar’s global presence and in-depth market expertise across the product journey remove barriers to launch and optimise pathways to life changing therapies.
UBC
UBC Connects specialty therapies to the patients who need them most by delivering modern, customized solutions in access, safety, and evidence generation.
We provide expert-driven real-world evidence tailored to specialty patient populations to uncover more valuable insights, maximize commercial positioning, and optimize regulatory approval for the long-term value of your therapy.
Exhibition Partner:
Pinex
Pinex is a referenced logistic operator in Brazil, with expertise in Clinical Trials, NPP, and Early Access Programs categorized in Brazil as Expanded Access, Compassionate Use, and Post-Trial Access, in which Pinex can manage the approval at Anvisa and perform the regulatory activities required locally.
Pinex, as a licensed wholesaler, can source comparator drugs and provide the following services, Regulatory Affairs, Importation, Warehousing, and Distribution.
